The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
Official Title: A Randomized, Double-blind Study To Evaluate the Efficacy and Safety of Cabozantinib (XL184) at 60 mg/Day Compared to a 140 mg/Day in Progressive, Metastatic Medullary Thyroid Cancer Patients
Study ID: NCT01896479
Brief Summary: The objective of this study is to evaluate the efficacy and safety of oral cabozantinib at a 60 mg dose compared with a 140 mg dose in subjects with progressive, metastatic MTC. It will test if the lower dose results in similar progression free survival (PFS) and overall response rate (ORR) with fewer adverse events compared to the PFS, ORR and adverse events found in previous clinical trials of 140 mg.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
, St. Leonards, New South Wales, Australia
, Herston, Queensland, Australia
, Kurralta Park, South Australia, Australia
, Parkville, Victoria, Australia
, Québec, Quebec, Canada
, Toronto, , Canada
, Osijek, , Croatia
, Zagreb, , Croatia
, Zagreb, , Croatia
, Bordeaux, Gironde, France
, Angers, Maine-et-Loire, France
, Lyon, Rhône, France
, Villejuif, Val-de-Marne, France
, Dijon, , France
, Paris, , France
, Strasbourg Cedex, , France
, Budapest, , Hungary
, Debrecen, , Hungary
, Jerusalem, , Israel
, Petach Tikva, , Israel
, Safed, , Israel
, Catania, CT, Italy
, Roma, RM, Italy
, Sienna, SI, Italy
, Pisa, Toscana, Italy
, Milano, , Italy
, Padua, , Italy
, Torino, , Italy
, Goyang, Gyeonggido, Korea, Republic of
, Seoul, , Korea, Republic of
, Seoul, , Korea, Republic of
, Amsterdam, Noord Holland, Netherlands
, Leiden, Zuid-Holland, Netherlands
, Groningen, , Netherlands
, Gliwice, Slaskie, Poland
, Poznań, Wielkopolskie, Poland
, Bucharest, , Romania
, Bucharest, , Romania
, Cluj-Napoca, , Romania
, Timisoara, , Romania
, Novosibirsk, , Russian Federation
, Obninsk, , Russian Federation
, St. Petersburg, , Russian Federation
, Yaroslavl, , Russian Federation
, Barcelona, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Lund, Skane Ian, Sweden
, Uppsala, Uppsala Ian, Sweden